The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Safin Sh.M.

Bashkir State Medical University

Derevyanko H.P.

Bashkir State Medical University

Blinova N.M.

Bashkir State Medical University

Progressive supranuclear paralysis with levodopa-induced dyskinesia

Authors:

Safin Sh.M., Derevyanko H.P., Blinova N.M.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(3): 110‑115

DOI: 10.17116/jnevro2021121031110

Read: 13903 times

Download PDF (RU)
Contact the author
Table of contents

PROGRESSIVE SUPRANUCLEAR PARALYSIS WITH LEVODOPA-INDUCED DYSKINESIA
PROGRESSIVE SUPRANUCLEAR PARALYSIS WITH LEVODOPA-INDUCED DYSKINESIA

To cite this article:

Safin ShM, Derevyanko HP, Blinova NM. Progressive supranuclear paralysis with levodopa-induced dyskinesia. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(3):110‑115. (In Russ.)
https://doi.org/10.17116/jnevro2021121031110

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Diagnosis and treatment approaches for sialorrhea in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):29-34
Neurochemical mechanisms of tremor in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):64-72
Clinical presentation and diagnosis of Parkinson’s disease in patients with schi­zophrenia spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):73-80
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
Bladder dysfunction in patients with stages I—III of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):91-99
Chro­nic epidural spinal cord stimulation for gait impairments in Parkinson’s disease and atypical parkinsonism. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):100-112
A portrait of a doctor with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):160-164
Pathomorphosis of the Parkinson’s disease against the background of DBS STN. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):21-27
The effect of bila­teral subthalamic nucleus deep brain stimulation on gait and bala­nce in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):94-101
Neuroinflammatory and neurodegenerative aspe­cts of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):102-111
Abstract:

Progressive supranuclear palsy (PNP) is a neurodegenerative disease characterized by a combination of progressive akinetic-rigid syndrome, postural instability with frequent falls, supranuclear ophthalmoplegia, pseudobulbar syndrome and frontal dementia. The disease usually develops after the sixth decade of life, and has a progressive course. An own description of the clinical case of progressive supranuclear palsy in a 79-year-old patient with oromandibular hyperkinesis while taking levodopa is presented.

Keywords:

supranuclear palsy
Steele—Richardson—Olszewski syndrome
Parkinson’s disease

Authors:

Safin Sh.M.

Bashkir State Medical University

Derevyanko H.P.

Bashkir State Medical University

Blinova N.M.

Bashkir State Medical University

Received:

09.04.2020

Accepted:

18.06.2020

Close metadata

References:

  1. Artem’ev DV, Golubev VL, Yakhno NN. Progressiruyushchii nad»yadernyi paralich. In: Yakhno N.N., Shtul’mana D.R, red. T. 2. Bolezni nervnoi sistemy. M.: Meditsina; 2001. (In Russ.).
  2. Mozolevsky YuV, Yakhno NN, Voznesenskaya TG, Kuuz RA. Progressive supranuclear palsy. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 1980;80(3):67-72. (In Russ.).
  3. Steele JC. Progressive supranuclear palsy. Historical notes. J Neural Transm Suppl. 1994;42:3-14. 
  4. Steele J, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogeneous system degeneration involving brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol. 1964;10:333-359.  https://doi.org/10.1001/archneur.1964.00460160003001
  5. Brusa A, Mancardi GL, Buigiani O. Progressive supranuclear palsy 1979: an overview. Ital J Neurol Sci. 1980;4:205-222.  https://doi.org/10.1007/bf02336701
  6. Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC. Prevalence and natural history of progressive supranuclear palsy. Neurology. 1988;38(7):1031-1034. https://doi.org/10.1212/wnl.38.7.1031
  7. Kawashima M, Miyake M, Kusumi M, et al. Prevalence of progressive supranuclear palsy in Yonago, Japan. Mov Disord. 2004;19(10):1239-1240. https://doi.org/10.1002/mds.20149
  8. Schrag A, Ben-Shlomo Y, Quinn NP. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet. 1999;354(9192):1771-1775. https://doi.org/10.1016/s0140-6736(99)04137-9
  9. Wenning GK, Litvan I, Tolosa E. Milestones in atypical and secondary Parkinsonisms. Mov Disord. 2011;26(6):1083-1095. https://doi.org/10.1002/mds.23713
  10. De Bruin VM, Lees AJ. Subcortical neurofibrillary degeneration presenting as Steele-Richardson-Olszewski and other related syndromes: a review of 90 pathologically verified cases. Mov Disord. 1994;9(4):381-389.  https://doi.org/10.1002/mds.870090402
  11. Santacruz P, Uttl B, Litvan I, Grafman J. Progressive supranuclear palsy: a survey of the disease course. Neurology. 1998;50(6):1637-1647. https://doi.org/10.1212/wnl.50.6.1637
  12. Irwin DJ. Tauopathies as clinicopathological entities. Parkinsonism Relat Disord. 2016;22:29-33.  https://doi.org/10.1016/j.parkreldis.2015.09.020
  13. Dickson DW, Ahmed Z, Algom AA, et al. Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol. 2010;23:394-400.  https://doi.org/10.1097/WCO.0b013e32833be924
  14. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47(1):1-9.  https://doi.org/10.1212/WNL.47.1.1
  15. Höglinger GU, Respondek G, Stamelou M, et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord. 2017;32:853-864.  https://doi.org/10.1002/mds.26987
  16. McFarland NR. Diagnostic Approach to Atypical Parkinsonian Syndromes. Continuum (Minneap Minn). 2016;22(4 Movement Disorders):1117-1142. https://doi.org/10.1212/CON.0000000000000348
  17. Ponomarev VV. Neirodegenerativnye zabolevaniya. SPb.: Foliant; 2013. (In Russ.).
  18. Fedotova EYu, Chechetkin AO, Ivanova-Smolenskaya IA, Illarioshkin SN. A case of progressive supranuclear palsy with corticobasal syndrome. Nervous Diseases. 2009;2:38-43. (In Russ.).
  19. Oba H, Yagishita A, Terada H, et al. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology. 2005;64(12):2050-2055. https://doi.org/10.1212/01.WNL.0000165960.04422.D0
  20. Gröschel K, Kastrup A, Litvan I, Schulz JB. Penguins and hummingbirds: midbrain atrophy in progressive supranuclear palsy. Neurology. 2006;66(6):949-950.  https://doi.org/10.1212/01.wnl.0000203342.77115.bf
  21. Righini A, Antonini A, De Notaris R, et al. MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. AJNR Am J Neuroradiol. 2004;25(6):927-932. 
  22. Josephs KA. Frontotemporal lobar degeneration. Neurol Clin. 2007;25(3):683-696.  https://doi.org/10.1016/j.ncl.2007.03.005
  23. Adachi M, Kawanami T, Ohshima H, et al. Morning glory sign: a particular MR finding in progressive supranuclear palsy. Magn Reson Med Sci. 2004;3(3):125-132.  https://doi.org/10.2463/mrms.3.125
  24. Kägi G, Bhatia KP, Tolosa E. The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry. 2010;81(1):5-12.  https://doi.org/10.1136/jnnp.2008.157370
  25. Kepe V, Bordelon Y, Boxer A, et al. PET imaging of neuropathology in tauopathies: progressive supranuclear palsy. J Alzheimers Dis. 2013;36(1):145-153.  https://doi.org/10.3233/JAD-130032
  26. Barclay CL, Lang AE. Dystonia in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 1997;62(4):352-356.  https://doi.org/10.1136/jnnp.62.4.352
  27. Stamelou M, Höglinger G. A Review of Treatment Options for Progressive Supranuclear Palsy. CNS Drugs. 2016;30(7):629-636.  https://doi.org/10.1007/s40263-016-0347-2
  28. Scelzo E, Lozano AM, Hamani C, et al. Peduncolopontine nucleus stimulation in progressive supranuclear palsy: a randomised trial. J Neurol Neurosurg Psychiatry. 2017;88(7):613-616.  https://doi.org/10.1136/jnnp-2016-315192
  29. Golbe LI, Ohman-Strickland PA. A clinical rating scale for progressive supranuclear palsy. Brain. 2007;130(Pt 6):1552-1565. https://doi.org/10.1093/brain/awm032
  30. Sale P, Castiglioni D, De Pandis MF, et al. The Lee Silverman Voice Treatment (LSVT) speech therapy in progressive supranuclear palsy. Eur J Phys Rehabil Med. 2015;51(5):569-574. 
  31. Apetauerova D, Scala SA, Hamill RW, et al. CoQ10 in progressive supranuclear palsy: A randomized, placebo-controlled, double-blind trial. Neurol Neuroimmunol Neuroinflamm. 2016;3(5):e266. https://doi.org/10.1212/NXI.0000000000000266
  32. O’Sullivan SS, Massey LA, Williams DR, et al. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain. 2008;131(Pt 5):1362-1372. https://doi.org/10.1093/brain/awn065
  33. Testa D, Monza D, Ferrarini M, et al. Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy. Neurol Sci. 2001;22(3):247-251.  https://doi.org/10.1007/s100720100021
  34. dell’Aquila C, Zoccolella S, Cardinali V, et al. Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients. Parkinsonism Relat Disord. 2013;19(11):980-985.  https://doi.org/10.1016/j.parkreldis.2013.06.014
  35. Pekmezović T, Ječmenica-Lukić M, Petrović I, et al. Quality of life in patients with progressive supranuclear palsy: one-year follow-up. J Neurol. 2015;262(9):2042-2048. https://doi.org/10.1007/s00415-015-7815-3
  36. Glasmacher SA, Leigh PN, Saha RA. Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88(5):402-411.  https://doi.org/10.1136/jnnp-2016-314956
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.